Evidence map›Paper›PMID 31681329›Full record

ArticleFrontiers in immunology2019

The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.

Seila Lorenzo-Herrero, Christian Sordo-Bahamonde, Gabriel Bretones, Ángel R Payer, Ana P González-Rodríguez, Esther González-García, Jhudit Pérez-Escuredo, Mónica Villa-Álvarez, Luz-Elena Núñez, Francisco Morís and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Seila Lorenzo-HerreroDepartamento de Biología Funcional, Inmunología, Universidad de Oviedo, Oviedo, Spain.
Christian Sordo-BahamondeDepartamento de Biología Funcional, Inmunología, Universidad de Oviedo, Oviedo, Spain.
Gabriel BretonesInstituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.
Ángel R PayerInstituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.
Ana P González-RodríguezInstituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.
Esther González-GarcíaDepartment of Hematology, Hospital de Cabueñes, Gijón, Spain.
Jhudit Pérez-EscuredoEntreChem S.L., Oviedo, Spain.
Mónica Villa-ÁlvarezDepartamento de Biología Funcional, Inmunología, Universidad de Oviedo, Oviedo, Spain.
Luz-Elena NúñezEntreChem S.L., Oviedo, Spain.
Francisco MorísEntreChem S.L., Oviedo, Spain.
Segundo GonzalezDepartamento de Biología Funcional, Inmunología, Universidad de Oviedo, Oviedo, Spain.
Alejandro López-SotoDepartamento de Biología Funcional, Inmunología, Universidad de Oviedo, Oviedo, Spain.
EntreChem (Spain) · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESUniversidad de Oviedo · ESHospital Universitario Central de Asturias · ESHospital Universitario De Cabueñes · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-cell receptor (BCR)-dependent signaling is central for leukemia B-cell homeostasis, as underscored by the promising clinical results obtained in patients with chronic lymphocytic leukemia (CLL) treated with novel agents targeting components of this pathway. Herein, we demonstrate that the mithralog EC-7072 displays high

Indexed as

Antibiotics, AntineoplasticApoptosisCaspase 3Cell SurvivalGene Expression ProfilingGene Expression Regulation, LeukemicHumansInterferon-gammaKiller Cells, NaturalLeukemia, Lymphocytic, Chronic, B-CellPhosphorylationPlicamycinReceptors, Antigen, B-CellSignal TransductionT-LymphocytesTumor Cells, CulturedAntibiotics, AntineoplasticCaspase 3Interferon-gammamithramycin SKPlicamycinReceptors, Antigen, B-CellapoptosisBCRCLLEC-7072mithralog

Identifiers

PMID31681329
PMCPMC6813538
OpenAlexW2968497951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.